Gleditsia javanica
Gleditsia javanica · Accepted scientific name
Scientific literature: Very Sparse (2 studies) · ★☆☆☆☆
Gleditsia javanica is a notable botanical species recognized for its diverse therapeutic potential in traditional medicine. The fruit of this plant is particularly valued, serving as a primary source for various medicinal applications. It contains significant concentrations of bioactive compounds, including potent flavonoids and terpenoids. These chemical constituents contribute to its documented antioxidant and anticancer activities. Furthermore, the plant is frequently utilized to manage health conditions such as conjunctivitis, cough, diarrhea, and dysentery.
- Synonyms
- Not available
- Common names
- Not available
- Family
- Not available
- Distribution
- Not available
- Plant Parts
- Fruit
Classification
Distribution
Identification
Biological Activities
Gleditsia javanica exhibits significant biological potential through its documented medicinal properties. Research indicates that the plant possesses notable anticancer activity, particularly through its ability to induce apoptosis in various cancer cell lines. Additionally, the species demonstrates strong antioxidant capabilities, which contribute to its overall therapeutic profile. These bioactive characteristics suggest that the plant is a rich source of phytochemicals like flavonoids and terpenoids. Such findings highlight the importance of further exploring its extracts for the development of novel therapeutic agents.
Compounds
Gleditsia javanica, also identified in research as Parkia javanica, serves as a significant medicinal plant known for its diverse chemical profile. This plant is recognized as a rich source of valuable secondary metabolites, specifically flavonoids and terpenoids. These bioactive compounds contribute to the plant's well-documented antioxidant and anti-inflammatory activities. Scientific investigations into its fruit and bark extracts have further revealed potent anti-proliferative and anti-angiogenic properties. Consequently, these phytochemicals represent promising candidates for the development of novel therapeutic agents in cancer management.
Conditions
Gleditsia javanica demonstrates significant therapeutic potential through its ability to treat various cancer cell lines, including A549, AGS, and MDA-MB435S. Research indicates that the extract induces cytotoxicity and apoptosis in these specific cellular targets. Beyond its anticancer properties, the plant is utilized in traditional medicine to treat ailments such as chronic piles. It is also recognized for its medicinal capacity to treat conjunctivitis. These diverse relationships highlight the plant's broad pharmacological applications in treating both cellular malignancies and common physical conditions.
Preparations
Parts used
Gleditsia javanica is a plant species where the fruit serves as a significant botanical component. In various medicinal studies, the fruit of related leguminous species has been identified as a potent source of bioactive compounds. Research indicates that extracts derived from these fruits can induce apoptosis in specific cancer cell lines through the intrinsic pathway. Furthermore, these fruit extracts have demonstrated notable anti-proliferative and anti-angiogenic properties in biological models. Such findings highlight the potential of utilizing the fruit as a natural resource for developing future therapeutic agents.